The global biosimilar monoclonal antibody comparability test platforms market is expected to witness substantial growth between 2026 and 2036, fueled by the rapid expansion of biosimilar drug pip...
The Europe Antibody Specificity Testing Market was valued at USD 214.94 million in 2024 and is projected to register a CAGR of 7.3% from 2025 to 2034, reaching USD 433.81 million by 2034. The mar...
The U.S. Antibody Specificity Testing Market was valued at USD 364.63 million in 2024 and is projected to reach USD 729.09 million by 2034, growing at a CAGR of 7.2% during the forecast period. T...
The Antibody Specificity Testing Market was valued at USD 928.06 million in 2024 and is anticipated to register a CAGR of 7.3% from 2025 to 2034, reaching USD 1,873.08 million by 2034. The market...
